Replies to post #45314 on OncoSec Medical Inc (ONCSQ)

[akhsv777]

Well, I believe it's not officially announced yet but most likely PISCES interim stage 1 data will be presented at the 33rd SITC 2018 scheduled 7-11 Nov in Washington D.C.

ONCS confirmed at the recent investment conference (31 Aug) that initial topline data release by the year end 2018 and file for potential FDA approval in 2019 via accelerated pathway.

Benefits of expedited regulatory allow ONCS to achieve rapid approval- TAVO is likely candidate to qualify for a rapid path to FDA approval.